Save Daliresp for SEVERE COPD Patients With Frequent Exacerbations
May 2015
New data will help clarify when to use Daliresp (roflumilast) to prevent COPD exacerbations.
You may hear that Daliresp decreases hospitalizations due to COPD exacerbations by 25%. This works out to one fewer hospitalization for every 24 severe COPD patients on Daliresp for a year.
Continue to maximize bronchodilators and inhaled steroids first. Ensure that patients are using their inhalers properly and consistently.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote